NCT01057030View on ClinicalTrials.gov

Multiple Dose Japanese Bridging Study

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Alzheimer Disease
Interventions
DRUG

BMS-708163

Capsules, Oral, 125 mg, once daily, 14 days

DRUG

Placebo

Capsules, Oral, 0 mg, once daily, 14 days

Trial Locations (1)

91206

California Clinical Trials Medical Group, Glendale

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01057030 - Multiple Dose Japanese Bridging Study | Biotech Hunter | Biotech Hunter